Clarithromycin susceptibility testing of Mycobacterium avium complex using 2,3-diphenyl-5-thienyl-(2)-tetrazolium chloride microplate assay with middlebrook 7H9 broth

Journal of Korean Medical Science

Volumn 24, Issue 3, 2009, Pages 511-512

  Park, Young Kil ^a   Koh, Won Jung ^b   Kim, Shin Ok ^a   Shin, Sonya ^c   Kim, Bum Joon ^d   Cho, Sang Nae ^e   Lee, Sun Min ^f   Chang, Chulhun L ^f,g  

^a Korean Institute of Tuberculosis   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d Seoul National University Hospital   (South Korea)

^e Yonsei University College of Medicine   (South Korea)

^f Pusan National University   (South Korea)

^g Pusan National University School of Medicine   (South Korea)

Author keywords

Clarithromycin; Microtiter method; Mycobacterium avium complex; Susceptibility testing; Tetrazolium

Indexed keywords

2,3 DIPHENYL 5 THIENYL (2) TETRAZOLIUM; 2,3-DIPHENYL-5-THIENYL-(2)-TETRAZOLIUM; CLARITHROMYCIN; TETRAZOLIUM;

CHEMISTRY; CULTURE MEDIUM; DRUG EFFECT; HUMAN; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MYCOBACTERIUM INTRACELLULARE AVIUM; NOTE;

CLARITHROMYCIN; CULTURE MEDIA; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM AVIUM COMPLEX; TETRAZOLIUM SALTS;

EID: 67649202051     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2009.24.3.511     Document Type: Note

References (10)

1. Jeon K, Koh WJ, Kwon OJ, Suh GY, Chung MP, Kim H, Lee NY, Park YK, Bai GH. Recovery rate of NTM from AFB smear-positive sputum specimens at a medical centre in South Korea. Int J Tuberc Lung Dis 2005; 9: 1046-51.
2. Koh WJ, Kwon OJ, Jeon K, Kim TS, Lee KS, Park YK, Bai GH. Clinical significance of nontuberculous mycobacteria isolated from respiratory specimens in Korea. Chest 2006; 129: 341-8.
3. Heifets LB. Clarithromycin against Mycobacterium avium complex infections. Tuber Lung Dis 1996; 77: 19-26.
4. Clinical and Laboratory Standards Institute. Susceptibility testing of mycobacteria, Norcardiae, and Other Aerobic Actinomycetes; Approved Standard. CLSI document M24-A. Wayne, Pa. USA: CLSI; 2003.
5. Shin JH, Choi JC, Lee JN, Kim HH, Lee EY, Chang CL. Evaluation of a colorimetric antifungal susceptibility test by using 2,3-diphenyl-5-thienyl-(2)-tetrazolium chloride. Antimicrob Agents Chemother 2004; 48: 4457-9.
6. Lee SM, Kim J, Jeong J, Park YK, Bai GH, Lee EY, Lee MK, Chang CL. Evaluation of the broth microdilution method using 2,3-diphenyl-5-thienyl-(2)-tetrazolium chloride for rapidly growing mycobacteria susceptibility testing. J Korean Med Sci 2007; 22: 784-90.
7. American Thoracic Society. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care Med 1997; 156: S1-25.
8. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M, Olivier K, Ruoss S, von Reyn CF, Wallace RJ Jr, Winthrop K. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175: 367-416.
9. Kawata N, Kawahara S, Tada A, Takigawa N, Shibayama T, Soda R, Takahashi K. Antimycobacterial susceptibility against nontuberculous mycobacteria using brothmic NTM. Kekkaku 2006; 81: 329-35.
10. Gomez-Flores R, Gupta S, Tamez-Guerra R, Mehta RT. Determination of MICs for Mycobacterium avium-M. intracellulare complex in liquid medium by a colorimetric method. J Clin Microbiol 1995; 33: 1842-6.